Erectile Dysfunction in Male Adults With Atopic Dermatitis and Psoriasis

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Erectile Dysfunction in Male Adults With Atopic Dermatitis and Psoriasis. / Egeberg, Alexander; Hansen, Peter R; Gislason, Gunnar H; Skov, Lone; Thyssen, Jacob P.

In: Journal of Sexual Medicine, Vol. 14, No. 3, 03.2017, p. 380-386.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Egeberg, A, Hansen, PR, Gislason, GH, Skov, L & Thyssen, JP 2017, 'Erectile Dysfunction in Male Adults With Atopic Dermatitis and Psoriasis', Journal of Sexual Medicine, vol. 14, no. 3, pp. 380-386. https://doi.org/10.1016/j.jsxm.2016.12.233

APA

Egeberg, A., Hansen, P. R., Gislason, G. H., Skov, L., & Thyssen, J. P. (2017). Erectile Dysfunction in Male Adults With Atopic Dermatitis and Psoriasis. Journal of Sexual Medicine, 14(3), 380-386. https://doi.org/10.1016/j.jsxm.2016.12.233

Vancouver

Egeberg A, Hansen PR, Gislason GH, Skov L, Thyssen JP. Erectile Dysfunction in Male Adults With Atopic Dermatitis and Psoriasis. Journal of Sexual Medicine. 2017 Mar;14(3):380-386. https://doi.org/10.1016/j.jsxm.2016.12.233

Author

Egeberg, Alexander ; Hansen, Peter R ; Gislason, Gunnar H ; Skov, Lone ; Thyssen, Jacob P. / Erectile Dysfunction in Male Adults With Atopic Dermatitis and Psoriasis. In: Journal of Sexual Medicine. 2017 ; Vol. 14, No. 3. pp. 380-386.

Bibtex

@article{45b74a0eefeb4665a39e7892b7c096ab,

title = "Erectile Dysfunction in Male Adults With Atopic Dermatitis and Psoriasis",

abstract = "INTRODUCTION: Patients with psoriasis have increased risk of cardiovascular disease, but data on atopic dermatitis (AD) are less clear-cut. However, it is well-established that erectile dysfunction (ED) can serve as a risk marker for coronary disease.AIM: To investigate the incidence, prevalence, and risk of ED in men with psoriasis and AD.METHODS: The sample included all Danish men at least 30 years old. In patients with AD and psoriasis, we determined disease severity based on use of systemic therapy. We performed a cross-sectional study (January 1, 2008) using logistic regression to estimate the prevalence and odds ratio of ED. Moreover, in a cohort study design, patients were followed from January 1, 2008 through December 31, 2012, and Cox regression models were used to estimate adjusted hazard ratios of new-onset ED. Models were adjusted for potential confounding factors, including age, socioeconomic status, health care consumption, smoking, alcohol abuse, diabetes, and cholesterol-lowering drug use.MAIN OUTCOME MEASURES: The outcome was initiation of pharmacotherapy used for treatment of ED.RESULTS: The sample consisted of 1,756,679 Danish men (age range = 30-100 years), of which 2,373 and 26,536 had adult AD (mild = 1,072; severe = 1,301) and psoriasis (mild = 21,775; severe = 4,761), respectively. Mean ages (SDs) were 53.0 (14.6), 46.7 (12.0), and 56.3 (13.8) years for the general population, patients with AD, and patients with psoriasis, respectively. Prevalences of ED were 8.7%, 6.7%, and 12.8% for the general population, patients with AD, and patients with psoriasis, respectively. Adjusted odds ratios (logistic regression) of ED were decreased in patients with AD (0.68; 0.57-0.80) but increased in those with psoriasis (1.15; 1.11-1.20). Adjusted odds ratios for mild and severe AD were 0.63 (0.48-0.82) and 0.72 (0.58-0.88), respectively, and those for psoriasis these were 1.16 (1.11-1.21) and 1.13 (1.03-1.23). Adjusted hazard ratios (Cox regression) were 0.92 (0.76-1.11) for AD and 1.14 (1.08-1.20) for psoriasis. The ED risk was not increased in men with mild AD (0.85; 0.63-1.14) or severe AD (0.97; 0.76-1.24) but was significantly increased in men with mild psoriasis (1.13; 1.09-1.20) and severe psoriasis (1.17; 1.04-1.32).CONCLUSION: We found an increased prevalence and risk of ED in men with psoriasis, whereas the risk was comparable to (and even slightly lower than) the general population for men with AD. Egeberg A, Hansen PR, Gislason GH, et al. Erectile Dysfunction in Male Adults With Atopic Dermatitis and Psoriasis. J Sex Med 2017;14:380-386.",

keywords = "Adult, Aged, Cardiovascular Diseases/epidemiology, Case-Control Studies, Cohort Studies, Comorbidity, Cross-Sectional Studies, Denmark/epidemiology, Dermatitis, Atopic/epidemiology, Erectile Dysfunction/epidemiology, Humans, Incidence, Logistic Models, Male, Middle Aged, Odds Ratio, Prevalence, Psoriasis/epidemiology, Risk Factors, Smoking/epidemiology",

author = "Alexander Egeberg and Hansen, {Peter R} and Gislason, {Gunnar H} and Lone Skov and Thyssen, {Jacob P}",

year = "2017",

month = mar,

doi = "10.1016/j.jsxm.2016.12.233",

language = "English",

volume = "14",

pages = "380--386",

journal = "Journal of Sexual Medicine",

issn = "1743-6095",

publisher = "Elsevier",

number = "3",

}

RIS

TY - JOUR

T1 - Erectile Dysfunction in Male Adults With Atopic Dermatitis and Psoriasis

AU - Egeberg, Alexander

AU - Hansen, Peter R

AU - Gislason, Gunnar H

AU - Skov, Lone

AU - Thyssen, Jacob P

PY - 2017/3

Y1 - 2017/3

N2 - INTRODUCTION: Patients with psoriasis have increased risk of cardiovascular disease, but data on atopic dermatitis (AD) are less clear-cut. However, it is well-established that erectile dysfunction (ED) can serve as a risk marker for coronary disease.AIM: To investigate the incidence, prevalence, and risk of ED in men with psoriasis and AD.METHODS: The sample included all Danish men at least 30 years old. In patients with AD and psoriasis, we determined disease severity based on use of systemic therapy. We performed a cross-sectional study (January 1, 2008) using logistic regression to estimate the prevalence and odds ratio of ED. Moreover, in a cohort study design, patients were followed from January 1, 2008 through December 31, 2012, and Cox regression models were used to estimate adjusted hazard ratios of new-onset ED. Models were adjusted for potential confounding factors, including age, socioeconomic status, health care consumption, smoking, alcohol abuse, diabetes, and cholesterol-lowering drug use.MAIN OUTCOME MEASURES: The outcome was initiation of pharmacotherapy used for treatment of ED.RESULTS: The sample consisted of 1,756,679 Danish men (age range = 30-100 years), of which 2,373 and 26,536 had adult AD (mild = 1,072; severe = 1,301) and psoriasis (mild = 21,775; severe = 4,761), respectively. Mean ages (SDs) were 53.0 (14.6), 46.7 (12.0), and 56.3 (13.8) years for the general population, patients with AD, and patients with psoriasis, respectively. Prevalences of ED were 8.7%, 6.7%, and 12.8% for the general population, patients with AD, and patients with psoriasis, respectively. Adjusted odds ratios (logistic regression) of ED were decreased in patients with AD (0.68; 0.57-0.80) but increased in those with psoriasis (1.15; 1.11-1.20). Adjusted odds ratios for mild and severe AD were 0.63 (0.48-0.82) and 0.72 (0.58-0.88), respectively, and those for psoriasis these were 1.16 (1.11-1.21) and 1.13 (1.03-1.23). Adjusted hazard ratios (Cox regression) were 0.92 (0.76-1.11) for AD and 1.14 (1.08-1.20) for psoriasis. The ED risk was not increased in men with mild AD (0.85; 0.63-1.14) or severe AD (0.97; 0.76-1.24) but was significantly increased in men with mild psoriasis (1.13; 1.09-1.20) and severe psoriasis (1.17; 1.04-1.32).CONCLUSION: We found an increased prevalence and risk of ED in men with psoriasis, whereas the risk was comparable to (and even slightly lower than) the general population for men with AD. Egeberg A, Hansen PR, Gislason GH, et al. Erectile Dysfunction in Male Adults With Atopic Dermatitis and Psoriasis. J Sex Med 2017;14:380-386.

AB - INTRODUCTION: Patients with psoriasis have increased risk of cardiovascular disease, but data on atopic dermatitis (AD) are less clear-cut. However, it is well-established that erectile dysfunction (ED) can serve as a risk marker for coronary disease.AIM: To investigate the incidence, prevalence, and risk of ED in men with psoriasis and AD.METHODS: The sample included all Danish men at least 30 years old. In patients with AD and psoriasis, we determined disease severity based on use of systemic therapy. We performed a cross-sectional study (January 1, 2008) using logistic regression to estimate the prevalence and odds ratio of ED. Moreover, in a cohort study design, patients were followed from January 1, 2008 through December 31, 2012, and Cox regression models were used to estimate adjusted hazard ratios of new-onset ED. Models were adjusted for potential confounding factors, including age, socioeconomic status, health care consumption, smoking, alcohol abuse, diabetes, and cholesterol-lowering drug use.MAIN OUTCOME MEASURES: The outcome was initiation of pharmacotherapy used for treatment of ED.RESULTS: The sample consisted of 1,756,679 Danish men (age range = 30-100 years), of which 2,373 and 26,536 had adult AD (mild = 1,072; severe = 1,301) and psoriasis (mild = 21,775; severe = 4,761), respectively. Mean ages (SDs) were 53.0 (14.6), 46.7 (12.0), and 56.3 (13.8) years for the general population, patients with AD, and patients with psoriasis, respectively. Prevalences of ED were 8.7%, 6.7%, and 12.8% for the general population, patients with AD, and patients with psoriasis, respectively. Adjusted odds ratios (logistic regression) of ED were decreased in patients with AD (0.68; 0.57-0.80) but increased in those with psoriasis (1.15; 1.11-1.20). Adjusted odds ratios for mild and severe AD were 0.63 (0.48-0.82) and 0.72 (0.58-0.88), respectively, and those for psoriasis these were 1.16 (1.11-1.21) and 1.13 (1.03-1.23). Adjusted hazard ratios (Cox regression) were 0.92 (0.76-1.11) for AD and 1.14 (1.08-1.20) for psoriasis. The ED risk was not increased in men with mild AD (0.85; 0.63-1.14) or severe AD (0.97; 0.76-1.24) but was significantly increased in men with mild psoriasis (1.13; 1.09-1.20) and severe psoriasis (1.17; 1.04-1.32).CONCLUSION: We found an increased prevalence and risk of ED in men with psoriasis, whereas the risk was comparable to (and even slightly lower than) the general population for men with AD. Egeberg A, Hansen PR, Gislason GH, et al. Erectile Dysfunction in Male Adults With Atopic Dermatitis and Psoriasis. J Sex Med 2017;14:380-386.

KW - Adult

KW - Aged

KW - Cardiovascular Diseases/epidemiology

KW - Case-Control Studies

KW - Cohort Studies

KW - Comorbidity

KW - Cross-Sectional Studies

KW - Denmark/epidemiology

KW - Dermatitis, Atopic/epidemiology

KW - Erectile Dysfunction/epidemiology

KW - Humans

KW - Incidence

KW - Logistic Models

KW - Male

KW - Middle Aged

KW - Odds Ratio

KW - Prevalence

KW - Psoriasis/epidemiology

KW - Risk Factors

KW - Smoking/epidemiology

U2 - 10.1016/j.jsxm.2016.12.233

DO - 10.1016/j.jsxm.2016.12.233

M3 - Journal article

C2 - 28109691

VL - 14

SP - 380

EP - 386

JO - Journal of Sexual Medicine

JF - Journal of Sexual Medicine

SN - 1743-6095

IS - 3

ER -

ID: 195543478